These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14457164)

  • 1. Statement on H.R. 6471 on behalf of the Pharmaceutical Manufacturers Association.
    KLUMPP TG
    New Physician; 1962 Mar; 11():A74-A77. PubMed ID: 14457164
    [No Abstract]   [Full Text] [Related]  

  • 2. [Swiss pharmaceutical legislation].
    GIRARDET ME
    Prod Pharm; 1960 Mar; 15():130-1. PubMed ID: 13828130
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmaceutical legislation in Great Britain].
    GIRARDET E
    Prod Pharm; 1960 Feb; 15():84-6. PubMed ID: 13828129
    [No Abstract]   [Full Text] [Related]  

  • 4. REGULATION governing the establishment and operation of pharmaceutical drug, and/or biological manufacturing laboratories, and the distribution and sale of pharmaceutical and biologic products.
    J Philipp Med Assoc; 1953 Feb; 29(2):74-82. PubMed ID: 13035712
    [No Abstract]   [Full Text] [Related]  

  • 5. [Permits for patent medicines and the right of transferring them].
    MARTELLIERE E
    Prod Pharm; 1961 Jan; 16():28-9. PubMed ID: 13767279
    [No Abstract]   [Full Text] [Related]  

  • 6. Hospitals and the drug controversy.
    SMITH A
    Hosp Manage; 1962 Jan; 93():34-6. PubMed ID: 13914110
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacy bills like Massachusetts House Bill No. 743 must be killed.
    GOODNESS JH
    SD J Med Pharm; 1953 Jun; 6(6):161-4. PubMed ID: 13076753
    [No Abstract]   [Full Text] [Related]  

  • 8. [The course of pharmacy legislation and pharmaceutical industry legislation in the German Democratic Republic].
    KRUEGER G
    Pharmazie; 1959 Nov; 14():157-61. PubMed ID: 14412213
    [No Abstract]   [Full Text] [Related]  

  • 9. [Brevet legislation for pharmaceutical products in Germany].
    EISHOLD KW
    Farmaco Prat; 1960 Jan; 15():3-11. PubMed ID: 13849694
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Decree of 7 April 1960 on the manufacture, distribution and sale of pharmaceutical products].
    MARTELLIERE E
    Prod Pharm; 1960 Aug; 15():366-73 concl. PubMed ID: 13767280
    [No Abstract]   [Full Text] [Related]  

  • 11. The new Restatement (Third) of Torts--shelter from the product liability storm for pharmaceutical companies and medical device manufacturers?
    Wagner MJ; Peterson LL
    Food Drug Law J; 1998; 53(2):225-42. PubMed ID: 10346683
    [No Abstract]   [Full Text] [Related]  

  • 12. The Food and Drug Administration and the Pharmaceutical industry.
    KLUMPP TG
    J Indiana State Med Assoc; 1961 Nov; 54():1680-90. PubMed ID: 14457165
    [No Abstract]   [Full Text] [Related]  

  • 13. Kefauver-Celler bill: a threat to medical progress.
    LAMME L
    GP; 1961 Oct; 24():173-7. PubMed ID: 14461811
    [No Abstract]   [Full Text] [Related]  

  • 14. The control of drugs.
    KERLAND I
    Hosp Prog; 1953 Oct; 34(10):98-102. PubMed ID: 13096047
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience under the revised drug regulations.
    MEYERS EL
    Bull Parenter Drug Assoc; 1961; 15():8-18. PubMed ID: 14473198
    [No Abstract]   [Full Text] [Related]  

  • 16. "Our common goals".
    LARRICK GP
    J New Drugs; 1962; 2():183-7. PubMed ID: 14462481
    [No Abstract]   [Full Text] [Related]  

  • 17. POSTAL treatment.
    Lancet; 1955 Feb; 268(6858):301. PubMed ID: 13234363
    [No Abstract]   [Full Text] [Related]  

  • 18. [Once more: Secret tricks of the illegal drug traffic].
    WILSCH
    Offentl Gesundheitsdienst; 1953 Mar; 14(12):475-6. PubMed ID: 13073101
    [No Abstract]   [Full Text] [Related]  

  • 19. China to blacklist wayward drug manufacturers.
    Parry J
    BMJ; 2014 Jan; 348():g243. PubMed ID: 24424287
    [No Abstract]   [Full Text] [Related]  

  • 20. Pressure on pharmacy benefit managers for disclosure and demonstration of value--rebates and drug benefit cost savings.
    Curtiss FR
    J Manag Care Pharm; 2003; 9(4):369-71. PubMed ID: 14613459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.